Loading company…
ShengYa Bio develops and produces in vitro diagnostic reagents and equipment.
Founded in 2018 and based in Xiamen, China, ShengYa Bio researches, develops, and produces in vitro diagnostic reagents and equipment. It raised Series B funding in December 2025 from Shanghai Chengpu Investment and CDIB Capital Group. The funding is intended to support product research and development and market expansion.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in